Janone Inc. (NASDAQ:ALTS) Short Interest Down 37.3% in November

Janone Inc. (NASDAQ:ALTS) was the recipient of a significant drop in short interest in November. As of November 30th, there was short interest totalling 80,700 shares, a drop of 37.3% from the November 15th total of 128,800 shares. Based on an average daily volume of 178,800 shares, the short-interest ratio is currently 0.5 days. Approximately 0.6% of the shares of the company are short sold.

Janone Price Performance

NASDAQ ALTS opened at $3.92 on Friday. The company has a 50 day simple moving average of $2.41. Janone has a 12-month low of $0.46 and a 12-month high of $5.26. The company has a debt-to-equity ratio of 1.96, a quick ratio of 0.75 and a current ratio of 0.75.

About Janone

JanOne Inc, a clinical-stage biopharmaceutical company, focuses on identifying, acquiring, licensing, developing, partnering, and commercializing novel, non-opioid, and non-addictive therapies to address the unmet medical need for the treatment of pain and addiction. It operates through three segments: Biotechnology, Recycling, and Technology.